Potential involvement of type II phospholipase A2 in atherosclerosis

Atherosclerosis

Volumn 132, Issue 1, 1997, Pages 1-8

  Hurt Camejo, E ^a   Camejo, G ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Atherosclerosis; Free fatty acids; Lysophospholipids; Phospholipids; Type II phospholipase A2

Indexed keywords

FATTY ACID; GLYCOSAMINOGLYCAN; LYSOPHOSPHOLIPID; PHOSPHOLIPASE A2;

ANIMAL TISSUE; ATHEROSCLEROSIS; CELL MOTILITY; ENDOTHELIUM CELL; ENZYME LOCALIZATION; ENZYME MODIFICATION; ENZYME SYNTHESIS; MEDIATOR RELEASE; MEMBRANE PERMEABILITY; MITOGENICITY; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SECOND MESSENGER; SECRETORY GRANULE; SMOOTH MUSCLE FIBER;

EID: 0030749386     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00085-3     Document Type: Article

References (91)

1. E.A. Dennis S.G. Rhee M.M. Billah Y.A. Hannun Role of phospholipases in generating lipid second messengers in signal transduction FASEB J 5 1991 2068 2077
2. A.J. Marcus D.P. Hajjar Vascular transcellular signaling J Lipid Res 34 1993 2017 2031
3. A.M. Evangelou Platelet-activating factor (PAF): implications for coronary heart and vascular diseases Prostaglandins Leuk Essent Fatty Acids 50 1994 1 28
4. W.H. Moolenaar Lysophosphatidic acid, a multifunctional phospholipid messenger J Biol Chem 270 1995 12949 12952
5. H. Esterbauer H.J. Gebicki H. Puhl G. Jürgens The role of lipid peroxidation and antioxidants in oxidative modification of LDL Free Radic Biol Med 13 1992 341 390
6. M. Toborek S.W. Barger M.P. Mattson S. Barve C.J. McClain B. Henning Linoleic acid and TNF- α cross-amplify oxidative injury and dysfunction of endothelial cells J Lipid Res 37 1996 123 135
7. M.T. Quinn S. Parthasarathy D. Steinberg Lysophosphatidylcholine: a chemotactic factor for human monocyte and its potential role in atherogenesis Proc Natl Acad Sci USA 85 1988 2805 2809
8. H.F. McMurray S. Parthasarathy D. Steinberg Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes J Clin Invest 92 1993 1004 1008
9. N. Kume M.A. Gimbrone Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells J Clin Invest 93 1994 907 911
10. T. Nakano E.W. Raines J.A. Abraham M. Klagsbrun R. Ross Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes Proc Natl Acad Sci USA 91 1994 1069 1073
11. T. Murohara R. Scalia A.M. Lefer Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells Cir Res 78 1996 780 789
12. M. Sakai A. Miyazaki H. Hakamata Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages J Biol Chem 269 1994 31430 31435
13. A. Stiko J. Regnström P.K. Shah B. Cercek J. Nilsson Active oxygen species and lysophosphatidylcholine are involved in oxidized low density lipoprotein activation of smooth muscle cell DNA synthesis Arterioscler Thromb Vasc Biol 16 1996 194 200
14. Y.-C. Chai P.H. Howe P.E. DiCorleto G.M. Chisolm Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cell J Biol Chem 271 1996 17791 17797
15. C.L. Cowan R.P. Steffen Lysophosphatidylcholine inhibits relaxation of rabbit abdominal aorta mediated by endothelium-derived nitric oxide and endothelium-derived hyperpolarizing factor independent of protein kinase C activation Arterioscler Thromb Vasc Biol 15 1995 2290 2297
16. J. Freeman W. Kuo B. Drenger T. Barnett M. Levine N. Flavahan Analysis of lysophosphatidylcholine-induced endothelial dysfunction J Cardiovasc Pharmacol 28 1996 345 352
17. G. Murugesan P.L. Fox Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein J Clin Invest 97 1996 2736 2744
18. P. Sivaram J.C. Obunike I.J. Goldberg Lysolecithin-induced alteration of subendothelial heparan sulfate proteoglycans increases monocyte binding to matrix J Biol Chem 270 1995 29760 29765
19. 2 in the pathobiology of disease Lab Invest 55 1986 391 404
20. 2 Blood 86 1995 4166 4174
21. Y. Yuan S.M. Schoenwaelder H.H. Salem S.P. Jackson The bioactive phospholipid, lysophosphatidylcholine, induces cellular effects via G-protein-dependent activation of adenylyl cyclase J Biol Chem 271 1996 27090 27098
22. 2 activity: implications for inflammatory diseases DNA Cell Biol 11 1992 233 243
23. 2 expression and inflammation: the relationship with associated disease states J Lipid Mediators 8 1993 1 30
24. 2 in psoriatic tissue Inflammation 18 1 1994 1 12
25. 2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cells FEBS Lett 1 1990 171 174
26. 2? Ann Surg 219 2 1994 183 192
27. 2 in human tissues Inflammation 17 1993 453 464
28. H. Van den Bosch Intracellular phospholipases A Biochim Biophys Acta 604 1980 191 246
29. 2: protection of membranes from lipid peroxidation damage TIBS 12 1987 31 34
30. 2 please stand up? J Clin Invest 97 1996 2161 2162
31. A.D. Cardin H.J.R. Weintraub Molecular modeling of protein-glycosaminoglycan interactions Arteriosclerosis 9 1988 21 31
32. H. Margalit N. Fischer S.A. Ben-Sasson Comparative analysis of structurally defined heparin binding sequences reveals a distinct spatial distribution of basic residues J Biol Chem 268 1993 19228 19231
33. R. Jackson S. Busch A. Cardin Glycosaminoglycans: molecular properties, protein interactions and role in physiological processes Physiol Rev 71 1991 481 539
34. L. Kjellen U. Lindahl Proteoglycans-structures and interactions Annu Rev Biochem 60 1991 443 475
35. Y. Tanaka D.H. Adams S. Shaw Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes Immunol Today 14 1993 111 115
36. G. Camejo E. Hurt-Camejo U. Olsson G. Bondjers Proteoglycans and lipoproteins in atherosclerosis Curr Opin Lipid 4 1993 385 391
37. T.N. Wight The extracellular matrix and atherosclerosis Curr Opin Lipid 6 1995 326 334
38. R.V. Iozzo A.D. Murdoch Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function FASEB J 10 1996 598 614
39. D.K. Strickland M.Z. Kounnas W.S. Argraves LDL receptor-related protein: a multiligand receptor for lipoprotein and proteinase catabolism FASEB J 9 1995 890 898
40. 2 J Biol Chem 264 10 1989 5768 5775
41. 2 by heparin Eur J Biochem 221 1994 481 490
42. 2 at 2.2 Å resolution Nature 352 1991 79 82
43. 2 type II to proteoglycans: differential effect of glycosaminoglycans on enzyme activity J Biol Chem 271 1996 26307 26314
44. Wight TN. The vascular extracellular matrix. In: Fuster V, Ross R, Topol E, editors. Atherosclerosis and Coronary Artery Disease. Philadelphia: Lippincott-Raven, 1996:421–440.
45. 2 associated with cell surfaces via C-terminal heparin-binding lysine residues augments stimulus-initiated delayed prostaglandin generation J Biol Chem 271 1996 30041 30051
46. 2 secreted and anchored on cell-surface heparan dulfate proteoglycans Eur J Biochem 218 1993 807 813
47. 2 Biochim Biophys Acta 1005 1989 270 276
48. 2 in normal and atherosclerotic arteries: activity of the isolated enzyme on low density lipoprotein. Arterioscler Thromb Vasc Biol 1996 (accepted).
49. 2 (type II) in human placenta and its possible involvment in normal parturition at term Prostaglandins Leuk Essent Fatty Acids 51 1994 19 26
50. 2 in human atherosclerotic plaques Atherosclerosis 118 1995 173 181
51. C.R. Stoner L.M. Reik M. Donohue W. Levin R.M. Crowl Human group II phospholipases A. Characterization of monoclonal antibodies and immunochemical quantitation of the protein in synovial fluid J Immunol Methods 145 1991 127 136
52. 2 Nature Struct Biol 2 6 1995 458 465
53. J.M. Whitelock A.D. Murdoch R.V. Iozzo P.A. Underwood The degradation of human endothelial cell-derived perlecan and release of bound fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases J Biol Chem 271 1996 10079 10086
54. 2: a novel mechanism for cell damage in inflammatory processes FEBS Lett 383 1996 75 78
55. −), a product of the myeloperoxidase system, degrades articular cartilage proteoglycan aggregate Free Radic Biol Med 10 1991 101 109
56. P. Libby Molecular bases of the acute coronary syndromes Circulation 91 1995 2844 2850
57. F. Wolfe D.M. Mitchell J.T. Sibley J.F. Fries D.A. Bloch C.A. Williams P.W. Spitz M. Haga S.M. Kleinheksel M.A. Cathey The mortality of rheumatoid arthritis Arthritis Rheum 4 1994 481 494
58. 2 Biochem J 309 1995 461 464
59. P. Libby Z.S. Galis Cytokines regulate genes involved in atherogenesis Ann New York Acad Sci 748 1995 158 170
60. 2 by rat mesanglial cells J Clin Invest 92 1993 2516 2523
61. 2 in rat cultured astrocytes J Biol Chem 266 1991 9956 9960
62. 2 involved in prostaglandin I2 synthesis in human umbilical vein endothelial cells J Biol Chem 268 1993 839 844
63. 2 gene expression in human hepatoma cells by mediators of the acute phase response J Biol Chem 266 1991 2647 2651
64. 2 in T-lymphocyte activation: implication in propagation of inflammatory reaction Proc Natl Acad Sci USA 90 1993 716 719
65. L. Jonasson J. Holm O. Skalli G. Bondjers G.K. Hansson Regional accumulation of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque Arteriosclerosis 6 1986 125 131
66. 2 J Biol Chem 269 18 1994 13057 13060
67. 2 Ann Rev Biochem 64 1995 653 688
68. V.N. Schumaker M.L. Phillips J.E. Chatterton Apolipoprotein B and low-density lipoprotein structure: implications for biosynthesiss of triglyceride-rich lipoproteins Adv Protein Chem 45 1994 236 244
69. L. Aggerebeck F.J. Kézdy A.M. Scanu Enzymatic probes of lipoprotein structure J Biol Chem 251 1976 3823 3830
70. 2 alters the expression of selected ApoB-100 epitopes and the interaction of LDL with cells J Lipid Res 29 1988 729 743
71. K.J. Williams I. Tabas The response-to-retention hypothesis of early atherogenesis Arterioscler Thromb Vasc Biol 15 1995 551 561
72. E.B. Smith Transport, interactions and retention of plasma proteins in the intima: the barrier function of the internal elastic lamina Eur Hear J 11 1990 72 81
73. G. Olsson O. Wiklund G. Bondjers Effects of injury on ApoB kinetics and concentration in rabbit aorta Arterioscler Thromb Vasc Biol 15 1995 930 936
74. 2 in expression of the scavenger pathway in cultured aortic smooth muscle cells stimulated with phorbol 12-myristate 13-acetate Biochem J 303 1994 247 253
75. A. Daugherty B.S. Zweifel B.E. Sobel G. Schonfeld Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits Arteriosclerosis 8 1988 768 777
76. A. Tailleux G. Torpier B. Caron J.-C. Fruchart C. Fievet Immunological properties of ApoB-containing lipoprotein particles in human atherosclerotic arteries J Lipid Res 34 1993 719 728
77. G. Camejo E. Hurt M. Romano Properties of lipoprotein complexes isolated by affinity chromatography from human aorta Biomed Biochim Acta 44 1985 389 401
78. J.F. Keaney A. Xu D. Cunningham T. Jackson B. Frei J.A. Vita Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation J Clin Invest 95 1995 2520 2529
79. E. Hurt-Camejo G. Camejo B. Rosengren F. López O. Wiklund G. Bondjers Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages J Lipid Res 31 1990 1387 1398
80. E. Hurt-Camejo G. Camejo B. Rosengren F. López C. Ahlström G. Fager G. Bondjers Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells Arterioscler Thromb 12 1992 569 583
81. D. Trible J.Mvd. van der Berg P.A. Motchnik B.N. Ames D.M. Lewis A. Chait R. Krauss Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and tocopherol content Proc Natl Acad Sci USA 91 1994 1183 1187
82. H.R. Superko Beyond LDL cholesterol reduction Circulation 94 1996 2351 2357
83. V. Anber B. Griffin M. McConnell C. Packard J. Sheperd Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans Atherosclerosis 124 1996 261 271
84. M. Navab J. Berliner A. Watson S. Hama M. Territo A. Lusis D. Shih B. Van Lenten J. Frank L. Demer P. Edwards A. Fogelman The yin and yang of oxidation in the development of the fatty streak Arterioscler Thromb Vascular Biology 16 1996 831 842
85. 2. A spin-label study Biochim Biophys Acta 1300 1996 103 113
86. S.L. Schissel J. Tweedie-Hardman J.H. Rapp G. Graham K.J. Williams I. Tabas Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein J Clin Invest 98 1996 1455 1464
87. 2-modified low density lipoprotein by human adipocytes Biochem Cell Biol 68 1990 1243 1249
88. 2-modified LDL is taken up at enhanced rate by macrophages Biochem Biophys Res Commun 185 1992 465 472
89. E.B. Smith Y. Transport Interaction and retention of plasma proteins in the intima: the barrier function of the internal elastic lamina Eur Heart J 11 1990 72 81
90. U. Kragh-Hansen Molecular aspects of ligand binding to serum albumin Pharmacol Rev 33 1981 17 53
91. 2 mimics cell-mediated oxidative modification J Lipid Res 29 1988 745 753